Rezolute Inc (RZLT)

$4.91 +0.19 (4.03%)
Market Cap 454.50M
Revenue (ttm) 0.00
Net Income (ttm) -74.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,428,100
Avg Vol 1,937,528
Day's Range N/A - N/A
Shares Out 96.29M
Stochastic %K 45%
Beta 0.54
Analysts Strong Sell
Price Target $7.67

Company Profile

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 206 4507
Address:
275 Shoreline Drive, Suite 500, Redwood City, United States
Zeestallion
Zeestallion Aug. 3 at 10:22 PM
$VIVS 🔥🚀 LOAD UP Load up before this one runs Real catalysts stacking hard 📈 Big pharma invested Eli Lilly 👀 Pressure building up 🤯 Low float $RZLT 💰🤑 Like I said we get in early. Now load up on VIVS 💎🚀 $RAIN $CYAB Screenshot 👇
0 · Reply
Monty3030
Monty3030 Aug. 2 at 8:16 PM
$RZLT 21.07 Days to Cover 24.50% Short Interest
0 · Reply
laaarsas
laaarsas Aug. 1 at 11:14 AM
$RZLT is upLIFT still big risk? since sunRIZE failed? Is regulatory risk big?
1 · Reply
KONGLIVES1
KONGLIVES1 Jul. 30 at 4:42 PM
$RZLT volume volume volume ?
0 · Reply
oaksapollo
oaksapollo Jul. 30 at 3:31 PM
$RZLT Let's go FDA, we need that feedback. It's a simple, tiny study, should take a few days to review.
0 · Reply
KONGLIVES1
KONGLIVES1 Jul. 29 at 4:39 PM
$RZLT buying opportunity 
0 · Reply
KONGLIVES1
KONGLIVES1 Jul. 28 at 10:25 PM
$RZLT the after hours trading‘s been pretty good volume 
0 · Reply
KONGLIVES1
KONGLIVES1 Jul. 28 at 4:09 PM
$RZLT I believe FDA is going to be positive, and hopefully the conference today and tomorrow will also give us some good information 
1 · Reply
Larattad1
Larattad1 Jul. 28 at 11:30 AM
$RZLT how is https://finance.yahoo.com/technology/ai/articles/rezolve-ai-delivers-breakout-first-120000426.html news not increasing the value…
1 · Reply
KONGLIVES1
KONGLIVES1 Jul. 27 at 6:32 PM
$RZLT hopefully the two day conference coming will shake some information free 
0 · Reply
Latest News on RZLT
Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Jul 21, 2026, 7:30 AM EDT - 14 days ago

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Rezolute Slides: Corporate presentation

Jun 26, 2026, 7:00 AM EDT - 5 weeks ago

Rezolute Slides: Corporate presentation

Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society

Jun 17, 2026, 7:00 AM EDT - 6 weeks ago

Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society

Rezolute price target raised to $11, named a Best Idea at Guggenheim

2026-06-15T10:41:18.000Z - 7 weeks ago

Rezolute price target raised to $11, named a Best Idea at Guggenheim

Rezolute Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 3:45 PM EDT - 2 months ago

Rezolute Transcript: Jefferies Global Healthcare Conference 2026

Rezolute Slides: FY 2026

Jun 4, 2026, 3:45 PM EDT - 2 months ago

Rezolute Slides: FY 2026

Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society

Jun 4, 2026, 7:30 AM EDT - 2 months ago

Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society

Rezolute price target raised to $14 from $10 at Maxim

2026-06-03T15:04:08.000Z - 2 months ago

Rezolute price target raised to $14 from $10 at Maxim

Rezolute price target raised to $6 from $5 at Wedbush

2026-06-03T12:16:54.000Z - 2 months ago

Rezolute price target raised to $6 from $5 at Wedbush

Rezolute upgraded to Outperform from Market Perform at Citizens

2026-06-03T08:36:37.000Z - 2 months ago

Rezolute upgraded to Outperform from Market Perform at Citizens

Rezolute price target raised to $6 from $5 at BTIG

2026-06-02T19:55:11.000Z - 2 months ago

Rezolute price target raised to $6 from $5 at BTIG

Rezolute price target raised to $14 from $10 at Maxim

2026-06-02T19:00:14.000Z - 2 months ago

Rezolute price target raised to $14 from $10 at Maxim

Rezolute provides interim update on ersodetug study

2026-06-02T11:31:37.000Z - 2 months ago

Rezolute provides interim update on ersodetug study

Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism

Jun 2, 2026, 7:00 AM EDT - 2 months ago

Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism

Rezolute price target raised to $10 from $4 at Maxim

2026-05-14T14:28:58.000Z - 2 months ago

Rezolute price target raised to $10 from $4 at Maxim

Rezolute reports Q3 EPS (16c), consensus (17c)

2026-05-12T21:34:01.000Z - 2 months ago

Rezolute reports Q3 EPS (16c), consensus (17c)

Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update

May 12, 2026, 4:05 PM EDT - 2 months ago

Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update

Rezolute Earnings release: Q3 2026

May 12, 2026, 4:00 PM EDT - 2 months ago

Rezolute Earnings release: Q3 2026

Rezolute Quarterly report: Q3 2026

May 12, 2026, 4:00 PM EDT - 2 months ago

Rezolute Quarterly report: Q3 2026

Rezolute to Participate in Upcoming Investor Conferences

May 11, 2026, 7:00 AM EDT - 3 months ago

Rezolute to Participate in Upcoming Investor Conferences

Rezolute Slides: Corporate presentation

May 7, 2026, 7:00 AM EDT - 3 months ago

Rezolute Slides: Corporate presentation

Rezolute presents results from Phase 3 sunRIZE study of ersodetug at PES 2026

2026-05-01T16:21:30.000Z - 3 months ago

Rezolute presents results from Phase 3 sunRIZE study of ersodetug at PES 2026

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting

May 1, 2026, 12:15 PM EDT - 3 months ago

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting

Rezolute, Inc. Investigated by the Portnoy Law Firm

Apr 24, 2026, 9:00 AM EDT - 3 months ago

Rezolute, Inc. Investigated by the Portnoy Law Firm

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting

Apr 21, 2026, 7:00 AM EDT - 3 months ago

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting

Rezolute Slides: Corporate presentation

Mar 30, 2026, 7:00 AM EDT - 4 months ago

Rezolute Slides: Corporate presentation

Wedbush upgrades Rezolute as worst case scenario seems unlikely for cHI

2026-03-25T10:46:08.000Z - 4 months ago

Wedbush upgrades Rezolute as worst case scenario seems unlikely for cHI

Rezolute upgraded to Outperform from Neutral at Wedbush

2026-03-25T10:37:36.000Z - 4 months ago

Rezolute upgraded to Outperform from Neutral at Wedbush

Rezolute provides update on sunRIZE study following Type B meeting with FDA

2026-03-24T11:26:35.000Z - 4 months ago

Rezolute provides update on sunRIZE study following Type B meeting with FDA

Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

Mar 24, 2026, 7:00 AM EDT - 4 months ago

Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

Rezolute to Participate in the Citizens Life Sciences Conference

Mar 4, 2026, 7:00 AM EST - 5 months ago

Rezolute to Participate in the Citizens Life Sciences Conference

Rezolute management to meet with Maxim

2026-03-03T14:56:44.000Z - 5 months ago

Rezolute management to meet with Maxim

Rezolute reports Q2 EPS (22c), consensus (18c)

2026-02-12T21:16:42.000Z - 6 months ago

Rezolute reports Q2 EPS (22c), consensus (18c)

Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

Feb 12, 2026, 4:05 PM EST - 6 months ago

Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

Rezolute Quarterly report: Q2 2026

Feb 12, 2026, 4:00 PM EST - 6 months ago

Rezolute Quarterly report: Q2 2026

Rezolute Earnings release: Q2 2026

Feb 12, 2026, 4:00 PM EST - 6 months ago

Rezolute Earnings release: Q2 2026

Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Feb 4, 2026, 7:00 AM EST - 6 months ago

Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Rezolute price target raised to $2 from $1 at Wedbush

2026-01-08T13:05:22.000Z - 7 months ago

Rezolute price target raised to $2 from $1 at Wedbush

Rezolute shares findings from Expanded Access Program in tumor HI

2026-01-07T12:17:20.000Z - 7 months ago

Rezolute shares findings from Expanded Access Program in tumor HI

Rezolute shares observations from Phase 3 sunRIZE study in congenital HI

2026-01-07T12:10:43.000Z - 7 months ago

Rezolute shares observations from Phase 3 sunRIZE study in congenital HI

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

Jan 7, 2026, 7:00 AM EST - 7 months ago

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

Rezolute Slides: Corporate Presentation

Jan 7, 2026, 7:00 AM EST - 7 months ago

Rezolute Slides: Corporate Presentation

Rezolute, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RZLT

Dec 11, 2025, 2:39 PM EST - 8 months ago

Rezolute, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RZLT

Rezolute Transcript: Study Result

Dec 11, 2025, 8:30 AM EST - 8 months ago

Rezolute Transcript: Study Result

Rezolute Press release: Study Result

Dec 11, 2025, 8:30 AM EST - 8 months ago

Rezolute Press release: Study Result

Rezolute's rare disease drug fails main goal in late-stage trial

Dec 11, 2025, 7:05 AM EST - 8 months ago

Rezolute's rare disease drug fails main goal in late-stage trial

Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism

Dec 11, 2025, 7:00 AM EST - 8 months ago

Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism

Rezolute Transcript: AGM 2025

Nov 19, 2025, 6:00 PM EST - 9 months ago

Rezolute Transcript: AGM 2025

Rezolute Slides: Corporate Presentation

Nov 12, 2025, 7:00 AM EST - 9 months ago

Rezolute Slides: Corporate Presentation

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Nov 10, 2025, 5:30 PM EST - 9 months ago

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Rezolute Transcript: Status Update

Nov 10, 2025, 12:00 PM EST - 9 months ago

Rezolute Transcript: Status Update

Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

Nov 6, 2025, 4:05 PM EST - 9 months ago

Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

Rezolute Quarterly report: Q1 2026

Nov 6, 2025, 4:00 PM EST - 9 months ago

Rezolute Quarterly report: Q1 2026

Rezolute Earnings release: Q1 2026

Nov 6, 2025, 4:00 PM EST - 9 months ago

Rezolute Earnings release: Q1 2026

Rezolute to Host Virtual Investor Event on Ersodetug Development Program

Nov 5, 2025, 7:30 AM EST - 9 months ago

Rezolute to Host Virtual Investor Event on Ersodetug Development Program

Rezolute Proxy statement: Proxy Filing

Oct 7, 2025, 8:00 AM EDT - 10 months ago

Rezolute Proxy statement: Proxy Filing

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

Sep 17, 2025, 4:05 PM EDT - 11 months ago

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

Zeestallion
Zeestallion Aug. 3 at 10:22 PM
$VIVS 🔥🚀 LOAD UP Load up before this one runs Real catalysts stacking hard 📈 Big pharma invested Eli Lilly 👀 Pressure building up 🤯 Low float $RZLT 💰🤑 Like I said we get in early. Now load up on VIVS 💎🚀 $RAIN $CYAB Screenshot 👇
0 · Reply
Monty3030
Monty3030 Aug. 2 at 8:16 PM
$RZLT 21.07 Days to Cover 24.50% Short Interest
0 · Reply
laaarsas
laaarsas Aug. 1 at 11:14 AM
$RZLT is upLIFT still big risk? since sunRIZE failed? Is regulatory risk big?
1 · Reply
KONGLIVES1
KONGLIVES1 Jul. 30 at 4:42 PM
$RZLT volume volume volume ?
0 · Reply
oaksapollo
oaksapollo Jul. 30 at 3:31 PM
$RZLT Let's go FDA, we need that feedback. It's a simple, tiny study, should take a few days to review.
0 · Reply
KONGLIVES1
KONGLIVES1 Jul. 29 at 4:39 PM
$RZLT buying opportunity 
0 · Reply
KONGLIVES1
KONGLIVES1 Jul. 28 at 10:25 PM
$RZLT the after hours trading‘s been pretty good volume 
0 · Reply
KONGLIVES1
KONGLIVES1 Jul. 28 at 4:09 PM
$RZLT I believe FDA is going to be positive, and hopefully the conference today and tomorrow will also give us some good information 
1 · Reply
Larattad1
Larattad1 Jul. 28 at 11:30 AM
$RZLT how is https://finance.yahoo.com/technology/ai/articles/rezolve-ai-delivers-breakout-first-120000426.html news not increasing the value…
1 · Reply
KONGLIVES1
KONGLIVES1 Jul. 27 at 6:32 PM
$RZLT hopefully the two day conference coming will shake some information free 
0 · Reply
KONGLIVES1
KONGLIVES1 Jul. 27 at 3:41 PM
$RZLT hopefully this is just backfilling for it’s move up 
0 · Reply
KONGLIVES1
KONGLIVES1 Jul. 25 at 4:00 PM
$RZLT Friday’s Price action surprising to say the least, another head fake?
1 · Reply
AC_TRADER
AC_TRADER Jul. 24 at 1:16 PM
$RZLT Levels made with @TrendSpider https://share.trendspider.com/chart/RZLT/7594yyqtwj
1 · Reply
Monty3030
Monty3030 Jul. 23 at 7:15 PM
$RZLT Get ready for BOOM BOOM candles if we break $5.43!!
0 · Reply
Monty3030
Monty3030 Jul. 21 at 7:46 PM
$RZLT Need to break $5.43 and then we fly!!
1 · Reply
Marketman707
Marketman707 Jul. 21 at 6:29 PM
$RZLT glad I bought yesterday
0 · Reply
KONGLIVES1
KONGLIVES1 Jul. 21 at 3:45 PM
$RZLT i’ve been buying again on the big pull back and I’m being paid handsomely 
0 · Reply
oaksapollo
oaksapollo Jul. 21 at 3:38 PM
$RZLT $7.50 and $10 strike calls starting to light up. Suggests they will hear back from FDA by mid-Oct at the latest.
0 · Reply
focafoca99
focafoca99 Jul. 21 at 12:12 PM
$RZLT attends the BTIG Virtual Biotechnology Conference July 28-29, with management available for one-on-one investor meetings.
0 · Reply
Monty3030
Monty3030 Jul. 21 at 10:14 AM
$RZLT 17.16 Days to Cover 24.65% Short Interest
0 · Reply
Monty3030
Monty3030 Jul. 20 at 2:22 PM
$RZLT Someone is really confident for August option expiration!!
0 · Reply
Monty3030
Monty3030 Jul. 19 at 2:56 PM
$RZLT 14.97 Days to Cover 24.65% Short Interest
0 · Reply